Last $14.78 USD
Change Today +0.24 / 1.65%
Volume 189.3K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - regulus therapeutics inc (RGLS)

NameBoard RelationshipsTitleAge
Kleanthis G. Xanthopoulos Ph.D.137 RelationshipsChief Executive Officer, President, Principal Financial & Accounting Officer and Director56
Paul C. Grint M.D.47 RelationshipsChief Medical Officer56
David L. Szekeres 4 RelationshipsChief Business Officer, General Counsel and Secretary40

Board Members - regulus therapeutics inc (RGLS)

NameBoard RelationshipsPrimary CompanyAge
Stelios Papadopoulos Ph.D.100 RelationshipsExelixis, Inc.66
Kleanthis G. Xanthopoulos Ph.D.137 RelationshipsRegulus Therapeutics Inc.56
David Baltimore Ph.D.117 RelationshipsAriad Pharmaceuticals Inc.76
Bruce L. A. Carter Ph.D.213 RelationshipsXencor, Inc.71
Mark G. Foletta CPA37 RelationshipsAmylin Ohio LLC53

Executive Committees* - regulus therapeutics inc (RGLS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMark G. Foletta CPA 37 Relationships4 Executives
Compensation CommitteeBruce L. A. Carter Ph.D. 213 Relationships3 Executives
Nominating CommitteeStelios Papadopoulos Ph.D. 100 Relationships4 Executives
Corporate Governance CommitteeStelios Papadopoulos Ph.D. 100 Relationships4 Executives
View RGLS Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $14.78 USD +0.24

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.92 AUD +0.035
Galena Biopharma Inc $1.49 USD -0.02
Prosensa Holding NV $18.76 USD +0.10
Silence Therapeutics PLC 202.50 GBp 0.00
Tekmira Pharmaceuticals Corp C$16.42 CAD +0.22
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 77.8x
Price/Book 9.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 75.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.